Amalgamated Bank’s GenMark Diagnostics, Inc GNMK Stock Holding History

Amalgamated Bank’s Portfolio GNMK Stock Details GNMK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q2	–	Sell	-9,893	Closed	-$236K	–	2200
2021 Q1	$236K	Sell	9,893 -985	-9%	-$18.3K	0.01%	1397
2020 Q4	$159K	Buy	10,878 +66	+0.6%	+$875	0.01%	1484
2020 Q3	$154K	Sell	10,812 -41	-0.4%	-$627	0.01%	1353
2020 Q2	$160K	Buy	+10,853	New	+$110K	0.01%	1339
2020 Q1	–	Sell	-10,457	Closed	-$50K	–	1824
2019 Q4	$50K	Buy	+10,457	New	+$57.7K	﹤0.01%	1790

Amalgamated Bank's GNMK Position: Q2 2021 in Review

Amalgamated Bank sold out of GenMark Diagnostics, Inc (GNMK) in Q2 2021, closing a stake of 9,893 shares — an estimated $236K sold.

Amalgamated Bank first reported a position in GNMK in Q4 2019 and held it in 5 quarters. The position peaked at $236K in Q1 2021. 0 funds tracked by Wall St. Rank hold GNMK as of Q2 2021.

Amalgamated Bank reported no remaining GenMark Diagnostics, Inc position as of Q2 2021 after selling out during the quarter.
Amalgamated Bank sold 9,893 GenMark Diagnostics, Inc shares in Q2 2021, an estimated $236K.
Amalgamated Bank first reported a position in GenMark Diagnostics, Inc in Q4 2019 and held it in 5 quarters.
Amalgamated Bank's GenMark Diagnostics, Inc position peaked at $236K in Q1 2021.
0 funds tracked by Wall St. Rank held GenMark Diagnostics, Inc as of Q2 2021.

Based on Amalgamated Bank's 13F filing for Q2 2021, filed 16 Aug 2021.